The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Effects of Netarsudil Ophthalmic Solution on Aqueous Humor Dynamics in a Randomized Study in Humans

Published:2018-06 Issue:5 Volume:34 Page:380-386
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Kazemi Arash¹,McLaren Jay W.¹,Kopczynski Casey C.²³,Heah Theresa G.²³,Novack Gary D.⁴⁵,Sit Arthur J.¹

Affiliation:

1. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota.

2. Aerie Pharmaceuticals, Inc., Bedminster, New Jersey.

3. Aerie Pharmaceuticals, Inc., Durham, North Carolina.

4. Departments of Ophthalmology and Pharmacology, University of California, Davis, California.

5. PharmaLogic Development, Inc., San Rafael, California.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jop.2017.0138

Reference38 articles.

1. Emerging Trabecular Outflow Drugs

2. Discovery of the ROCK inhibitor netarsudil for the treatment of open-angle glaucoma

3. Fixed-dose combination of AR-13324 and latanoprost: a double-masked, 28-day, randomised, controlled study in patients with open-angle glaucoma or ocular hypertension

4. Double-masked, Randomized, Dose–Response Study of AR-13324 versus Latanoprost in Patients with Elevated Intraocular Pressure

5. Visualization of conventional outflow tissue responses to netarsudil in living mouse eyes

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography;Ophthalmology Science;2024-09

2. Ocular Pharmacology;The Journal of Clinical Pharmacology;2024-05-06

3. Rho Kinase Inhibitors: Strategies in Glaucoma Treatment in Older Adults;Drugs & Aging;2024-02-28

4. Identifying Baseline Predictors of Selective Laser Trabeculoplasty Effectiveness: An Alternative Mathematical Approach;Cureus;2024-02-13

5. Advantages and disadvantages of using Rho kinase inhibitors to reduce intraocular pressure;Expert Review of Ophthalmology;2024-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3